DeepSIBA: Chemical Structure-based Inference of Biological Alterations
Predicting whether a chemical structure shares a desired biological effect can have a significant impact for in-silico compound screening in early drug discovery. In this study, we developed a deep learning model where compound structures are represented as graphs and then linked to their biological footprint. To make this complex problem computationally tractable, compound differences were mapped to biological effect alterations using Siamese Graph Convolutional Neural Networks. The proposed model was able to learn new representations from chemical structures and identify structurally dissimilar compounds that affect similar biological processes with high precision. Additionally, by utilizing deep ensembles to estimate uncertainty, we were able to provide reliable and accurate predictions for chemical structures that are very different from the ones used during training. Finally, we present a novel inference approach, where the trained models are used to estimate the signaling pathways affected by a compound perturbation in a specific cell line, using only its chemical structure as input. As a use case, this approach was used to infer signaling pathways affected by FDA-approved anticancer drugs.
Code (1)
Tasks
Drug DiscoveryMethods 이 논문이 사용한 방법론
Similar Papers 제목 키워드 기반
Empowering Chemical Structures with Biological Insights for Scalable Phenotypic Virtual Screening
Motivation: The scalable identification of bioactive compounds is essential for contemporary drug discovery. This process faces a key trade-off: structural screening offers scalability but lacks biological context, where…
Drug DiscoveryEffects of fixatives on myelin molecular order probed with RP-CARS microscopy
When live imaging is not feasible, sample fixation allows preserving the ultrastructure of biological samples for subsequent microscopy analysis. This process could be performed with various methods, each one affecting d…
TiMEx: A Waiting Time Model for Mutually Exclusive Groups of Cancer Alterations
Despite recent technological advances in genomic sciences, our understanding of cancer progression and its driving genetic alterations remains incomplete. Here, we introduce TiMEx, a generative probabilistic model for de…
Computational EfficiencyIdentifying metabolites from protein identifiers with P2M
The identification of metabolites from complex biological samples often involves matching experimental mass spectrometry data to signatures of compounds derived from massive chemical databases. However, misidentification…
Extrinsic Fluctuations in the p53 Cycle
Fluctuations are inherent to biological systems, arising from the stochastic nature of molecular interactions, and influence various aspects of system behavior, stability, and robustness. These fluctuations can be catego…
Computational Efficiency